Join us next year in Chicago for the 2017 ASH Meeting on Hematologic Malignancies and gain knowledge that can help you make an immediate impact on your practice. The meeting will feature the top experts in the field, comprehensive clinical content, the latest clinical research, and opportunities to interact with colleagues in an intimate, small-group setting with no competing sessions.
The program content will be structured as "How I Treat" presentations which will showcase each speaker's evidence-based treatment approaches, present cutting-edge scientific data that can be translated into new strategies for diagnosis and treatment, and address what to do in cases where there is no data. Experts will provide out-of-the-box treatment approaches, answer challenging patient care questions during topic-based panel discussions, and engage in stimulating conversations on specific disease topics during Lunch with the Experts sessions.
The following core malignancies will be covered at the meeting:
With more than 17,000 members from nearly 100 countries, the American Society of Hematology (ASH) is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.